CHRS

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Coherus BioSciences Inc

NASDAQ | CHRS

1.21

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$153.51M

Market Cap

2.309

P/E Ratio

0.55

EPS

$1.95

52 Week High

$0.71

52 Week Low

HEALTHCARE

Sector

CHRS Chart

Recent Chart
Price Action

CHRS Technicals

Tags:

CHRS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $149M
Total Revenue $267M
Cost Of Revenue $118M
Costof Goods And Services Sold $118M
Operating Income -$112M
Selling General And Administrative $140M
Research And Development $93M
Operating Expenses $261M
Investment Income Net -
Net Interest Income -$27M
Interest Income -
Interest Expense $27M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.3M
Income Before Tax $29M
Income Tax Expense $29M
Interest And Debt Expense -
Net Income From Continuing Operations $29M
Comprehensive Income Net Of Tax -
Ebit $56M
Ebitda $61M
Net Income $29M

Revenue & Profitability

Earnings Performance

CHRS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $449M
Total Current Assets $342M
Cash And Cash Equivalents At Carrying Value $126M
Cash And Short Term Investments $126M
Inventory $70M
Current Net Receivables $122M
Total Non Current Assets $107M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $54M
Intangible Assets Excluding Goodwill $54M
Goodwill $0
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $23M
Other Non Current Assets -
Total Liabilities $581M
Total Current Liabilities $283M
Current Accounts Payable $28M
Deferred Revenue -
Current Debt -
Short Term Debt $1.7M
Total Non Current Liabilities $298M
Capital Lease Obligations $5M
Long Term Debt $265M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $270M
Other Current Liabilities $253M
Other Non Current Liabilities $28M
Total Shareholder Equity -$132M
Treasury Stock -
Retained Earnings -$1.6B
Common Stock $12K
Common Stock Shares Outstanding $115M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$20M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.3M
Capital Expenditures $0
Change In Receivables -
Change In Inventory -$32M
Profit Loss -
Cashflow From Investment $230M
Cashflow From Financing -$187M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $29M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $149M
Total Revenue $267M
Cost Of Revenue $118M
Costof Goods And Services Sold $118M
Operating Income -$112M
Selling General And Administrative $140M
Research And Development $93M
Operating Expenses $261M
Investment Income Net -
Net Interest Income -$27M
Interest Income -
Interest Expense $27M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.3M
Income Before Tax $29M
Income Tax Expense $29M
Interest And Debt Expense -
Net Income From Continuing Operations $29M
Comprehensive Income Net Of Tax -
Ebit $56M
Ebitda $61M
Net Income $29M

CHRS News

CHRS Profile

Coherus BioSciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Coherus BioSciences Inc. is an innovative biopharmaceutical company focused on developing and commercializing biosimilars and cutting-edge immuno-oncology therapies, primarily in the U.S. market. Headquartered in Redwood City, California, Coherus is dedicated to expanding patient access to high-quality biologic therapies while effectively lowering healthcare expenses. With a strong product pipeline and strategic partnerships, the company is well-positioned to meet the increasing demand for cost-effective treatment solutions in oncology and autoimmune diseases, making it an attractive investment opportunity in the rapidly evolving biotech landscape.

LPTX
+368.57%
$2.05
VRAX
+54.64%
$0.60
PAVS
-39.92%
$0.03
IXHL
+14.75%
$0.45
VHAI
0.00%
$0.00
IRBT
+60.25%
$3.12
TWOH
0.00%
$0.00
IPG
-1.95%
$24.57
NVDA
-0.60%
$180.36
AXDX
-61.36%
$0.03
ONDS
-2.81%
$7.84
JSPR
-8.13%
$1.58
NIO
-5.66%
$4.74
F
-1.51%
$12.96
ADAP
-15.14%
$0.05
TSLA
+2.65%
$440.65
AMZN
+0.23%
$234.42
SOND
-23.45%
$0.12
BYND
-4.55%
$1.23
INTC
+0.18%
$43.55
ASST
-1.93%
$1.01
RMBL
+60.50%
$3.21
QCLS
+20.41%
$4.07
CAPR
+345.75%
$28.35
LNW
-3.71%
$86.22
BTBT
-0.44%
$2.24
ADD
-25.47%
$0.05
RR
+1.96%
$3.63
IREN
+4.95%
$43.15
INHD
-9.37%
$0.13
SRM
+53.27%
$10.30
PLUG
+1.95%
$2.15
VALE
+2.87%
$13.26
MRVL
+3.97%
$96.58
BITF
-2.65%
$3.01
BMNR
+3.44%
$33.01
BMNU
+6.13%
$7.79
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
PFE
+2.12%
$25.68
NFLX
+0.20%
$109.35
SOFI
+0.16%
$29.55
AFMD
-34.94%
$0.18
KITT
+28.86%
$0.93
BBD
-2.46%
$3.57
IMRN
-12.06%
$1.53
PMAX
+23.73%
$2.80
HTOO
+14.85%
$4.02
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
MODV
-25.22%
$0.43
AAL
+0.56%
$14.32
QBTS
+2.12%
$22.97
TSLG
-0.64%
$9.21
DNN
+1.15%
$2.62
CMND
-13.27%
$0.11
AAPL
+0.06%
$286.39
CHR
-6.96%
$0.04
ASBP
-14.91%
$0.08
MSFT
-2.02%
$480.09
PLTD
-1.79%
$6.83
AMC
-2.12%
$2.30
MARA
+0.20%
$11.93
CIFR
-0.68%
$17.52
AEO
+14.17%
$23.78
AMD
+0.01%
$215.26
PYPL
-2.90%
$61.07
CLSK
+0.84%
$13.82
GOOGL
+1.42%
$320.32
ACHR
+3.50%
$7.91
KDLY
-2.95%
$0.48
CMG
-0.29%
$34.14
WULF
-4.04%
$13.64
SAND
-6.04%
$12.12
PLTR
+1.52%
$173.28
SHOT
-74.37%
$0.39
GTLB
-14.56%
$37.05
YGMZ
-14.61%
$0.07
BTG
+1.01%
$4.47
ZAPP
-46.30%
$0.15
LYFT
+3.73%
$22.24
KXIN
+27.41%
$3.95
BMY
+5.41%
$50.86
VIVK
-13.43%
$0.09
MSTR
-0.02%
$181.28
KEY
-0.72%
$18.28
SU
-1.91%
$43.94
HIMS
-3.19%
$36.31
PINS
+0.18%
$26.89
ON
+2.08%
$51.48
PSTG
-26.10%
$69.99
GPUS
-5.12%
$0.27
RGTI
-0.10%
$23.85
M
+0.15%
$22.74
NBIS
-3.69%
$96.45
GOOG
+1.57%
$321.01
CGC
+2.25%
$1.13
AG
-0.53%
$15.82
IONZ
+0.51%
$4.48
KVUE
-0.41%
$16.79
LPTX
+368.57%
$2.05
VRAX
+54.64%
$0.60
PAVS
-39.92%
$0.03
IXHL
+14.75%
$0.45
VHAI
0.00%
$0.00
IRBT
+60.25%
$3.12
TWOH
0.00%
$0.00
IPG
-1.95%
$24.57
NVDA
-0.60%
$180.36
AXDX
-61.36%
$0.03
ONDS
-2.81%
$7.84
JSPR
-8.13%
$1.58
NIO
-5.66%
$4.74
F
-1.51%
$12.96
ADAP
-15.14%
$0.05
TSLA
+2.65%
$440.65
AMZN
+0.23%
$234.42
SOND
-23.45%
$0.12
BYND
-4.55%
$1.23
INTC
+0.18%
$43.55
ASST
-1.93%
$1.01
RMBL
+60.50%
$3.21
QCLS
+20.41%
$4.07
CAPR
+345.75%
$28.35
LNW
-3.71%
$86.22
BTBT
-0.44%
$2.24
ADD
-25.47%
$0.05
RR
+1.96%
$3.63
IREN
+4.95%
$43.15
INHD
-9.37%
$0.13
SRM
+53.27%
$10.30
PLUG
+1.95%
$2.15
VALE
+2.87%
$13.26
MRVL
+3.97%
$96.58
BITF
-2.65%
$3.01
BMNR
+3.44%
$33.01
BMNU
+6.13%
$7.79
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
PFE
+2.12%
$25.68
NFLX
+0.20%
$109.35
SOFI
+0.16%
$29.55
AFMD
-34.94%
$0.18
KITT
+28.86%
$0.93
BBD
-2.46%
$3.57
IMRN
-12.06%
$1.53
PMAX
+23.73%
$2.80
HTOO
+14.85%
$4.02
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
MODV
-25.22%
$0.43
AAL
+0.56%
$14.32
QBTS
+2.12%
$22.97
TSLG
-0.64%
$9.21
DNN
+1.15%
$2.62
CMND
-13.27%
$0.11
AAPL
+0.06%
$286.39
CHR
-6.96%
$0.04
ASBP
-14.91%
$0.08
MSFT
-2.02%
$480.09
PLTD
-1.79%
$6.83
AMC
-2.12%
$2.30
MARA
+0.20%
$11.93
CIFR
-0.68%
$17.52
AEO
+14.17%
$23.78
AMD
+0.01%
$215.26
PYPL
-2.90%
$61.07
CLSK
+0.84%
$13.82
GOOGL
+1.42%
$320.32
ACHR
+3.50%
$7.91
KDLY
-2.95%
$0.48
CMG
-0.29%
$34.14
WULF
-4.04%
$13.64
SAND
-6.04%
$12.12
PLTR
+1.52%
$173.28
SHOT
-74.37%
$0.39
GTLB
-14.56%
$37.05
YGMZ
-14.61%
$0.07
BTG
+1.01%
$4.47
ZAPP
-46.30%
$0.15
LYFT
+3.73%
$22.24
KXIN
+27.41%
$3.95
BMY
+5.41%
$50.86
VIVK
-13.43%
$0.09
MSTR
-0.02%
$181.28
KEY
-0.72%
$18.28
SU
-1.91%
$43.94
HIMS
-3.19%
$36.31
PINS
+0.18%
$26.89
ON
+2.08%
$51.48
PSTG
-26.10%
$69.99
GPUS
-5.12%
$0.27
RGTI
-0.10%
$23.85
M
+0.15%
$22.74
NBIS
-3.69%
$96.45
GOOG
+1.57%
$321.01
CGC
+2.25%
$1.13
AG
-0.53%
$15.82
IONZ
+0.51%
$4.48
KVUE
-0.41%
$16.79
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.